An Tong Selected Research

Retained Placenta

9/2019

Management of postpartum pulmonary embolism combined with retained placenta accreta: A case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

An Tong Research Topics

Disease

4	Neoplasms (Cancer) 01/2022 - 01/2018
2	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 12/2021
2	Ovarian Epithelial Carcinoma 01/2023 - 12/2021
2	Ascites 01/2022 - 12/2021
2	Necrosis 10/2021 - 09/2019
1	Carcinoma (Carcinomatosis) 01/2023
1	Infections 09/2019
1	Retained Placenta 09/2019
1	Pulmonary Embolism 09/2019
1	Hemangiosarcoma (Angiosarcoma) 01/2019

Drug/Important Bio-Agent (IBA)

1	PhosphoserineIBA 01/2022
1	PhosphatidylserinesIBA 01/2022
1	Mechanistic Target of Rapamycin Complex 2IBA 12/2021
1	vistusertibIBA 12/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 12/2021
1	CaspasesIBA 10/2021
1	Adenosine Triphosphatases (ATPase)IBA 10/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2019
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 09/2019
1	AnticoagulantsIBA 09/2019
1	Warfarin (Coumadin)FDA LinkGeneric 09/2019
1	Mifepristone (RU 486)FDA Link 09/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2018

Therapy/Procedure

2	Therapeutics 01/2022 - 09/2019
1	Drug Therapy (Chemotherapy) 01/2023
1	Immunotherapy 01/2023